Search

Your search keyword '"Carter, Melody C."' showing total 286 results

Search Constraints

Start Over You searched for: Author "Carter, Melody C." Remove constraint Author: "Carter, Melody C." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
286 results on '"Carter, Melody C."'

Search Results

1. A widespread blistering eruption: diffuse cutaneous mastocytosis

2. Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

3. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

6. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms

9. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

10. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

11. Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

12. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

13. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

14. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group

17. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

19. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

29. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

37. Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms

38. Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

39. Refined treatment response criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium

40. Standards of genetic testing in the diagnosis and prognostication of systemic mastocytosis in 2022: Recommendations of the EU-US cooperative group

41. Standards of pathology in the diagnosis of systemic mastocytosis: recommendations of the EU-US cooperative group

42. Personalized management strategies in mast cell disorders: ECNM-AIM User's guide for daily clinical practice

46. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

49. Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference

50. Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference

Catalog

Books, media, physical & digital resources